ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 130 filers reported holding ALLAKOS INC in Q2 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $187,269 | -81.5% | 42,083 | -65.0% | 0.00% | -83.3% |
| Q4 2022 | $1,013,179 | +142.4% | 120,330 | +76.1% | 0.02% | +125.0% |
| Q3 2022 | $418,000 | -44.8% | 68,334 | -71.8% | 0.01% | -61.9% |
| Q2 2022 | $757,000 | -61.3% | 241,902 | -29.6% | 0.02% | -59.6% |
| Q1 2022 | $1,958,000 | +6.9% | 343,430 | +83.5% | 0.05% | -8.8% |
| Q4 2021 | $1,832,000 | – | 187,125 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |